To search for potential factors that could be mediating the inhibitory effect of CAFs from shBrca2 tumors on T-cells, we mined our tumor-derived CAF RNA-seq data from KPC tumors using the ICELLNET receptor-ligand analysis tool employing a CD8+ T-cell-receptor dataset87. This evidence concerns the gene CD8A and neoplasm.